Elafibranor (Iqirvo) was well tolerated and led to sustained improvements in liver enzyme levels and itch severity through 28 weeks in patients with primary sclerosing cholangitis (PSC), according to ...
The Independent on MSN
New ‘wonder drug’ could cut your cholesterol in half - after just one dose
The single dose treatment helped patients lower “bad” cholesterol and triglyerides, both linked to heart disease ...
CRISPR Therapeutics' CEO said he hoped to have a product on the market in the next four or five years. Read more at ...
A sluggish liver refers the organ’s impaired function, leading to poor detoxification and other functions. Some symptoms of the same can include fatigue, digestive issues like bloating or constipation ...
Low blood pressure, or hypotension, can be dangerous as it impairs oxygen delivery to vital organs. When mean arterial pressure drops, organs like the ...
(GLOBE NEWSWIRE) -- (NASDAQ: NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today presented positive clinical data from a pooled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback